U
Primo Nutraceuticals Inc.
BUGVF
OTC PK
E
Sell
6/21/2021Downgrade
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 6/21/2021 due to a decline in the total return index and volatility index.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 6/21/2021 due to a decline in the total return index and volatility index.
D
Sell
1/13/2021Upgraded
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 1/13/2021 due to an increase in the total return index.
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 1/13/2021 due to an increase in the total return index.
E
Sell
12/29/2020Downgrade
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 12/29/2020 due to a decline in the valuation index.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 12/29/2020 due to a decline in the valuation index.
D
Sell
12/14/2020Upgraded
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 12/14/2020 due to an increase in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 12/14/2020 due to an increase in the volatility index and total return index.
E
Sell
9/11/2020Downgrade
Primo Nutraceuticals Inc. (BUGVD) was downgraded to E+ from D- on 9/11/2020 due to a decline in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVD) was downgraded to E+ from D- on 9/11/2020 due to a decline in the volatility index and total return index.
D
Sell
8/27/2020Upgraded
Primo Nutraceuticals Inc. (BUGVD) was upgraded to D- from E+ on 8/27/2020 due to a noticeable increase in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVD) was upgraded to D- from E+ on 8/27/2020 due to a noticeable increase in the volatility index and total return index.
E
Sell
7/10/2020Downgrade
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 7/10/2020 due to a substantial decline in the growth index, solvency index and valuation index. EBIT declined 413.35% from -$36.7 to -$188.4, earnings per share declined from -$0.0005 to -$0.0013, and debt to equity increased from 0.46 to 0.84.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 7/10/2020 due to a substantial decline in the growth index, solvency index and valuation index. EBIT declined 413.35% from -$36.7 to -$188.4, earnings per share declined from -$0.0005 to -$0.0013, and debt to equity increased from 0.46 to 0.84.
D
Sell
6/15/2020Upgraded
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 6/15/2020 due to an increase in the volatility index and solvency index.
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E+ on 6/15/2020 due to an increase in the volatility index and solvency index.
E
Sell
5/29/2020Downgrade
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 5/29/2020 due to a decline in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E+ from D- on 5/29/2020 due to a decline in the volatility index and total return index.
D
Sell
5/18/2020Downgrade
Primo Nutraceuticals Inc. (BUGVF) was downgraded to D- from D on 5/18/2020 due to a decline in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to D- from D on 5/18/2020 due to a decline in the volatility index and total return index.
D
Sell
5/1/2020Upgraded
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D from D- on 5/1/2020 due to an increase in the valuation index, growth index and solvency index. EBIT increased 82.39% from -$208.4 to -$36.7, and earnings per share increased from -$0.0019 to -$0.0005.
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D from D- on 5/1/2020 due to an increase in the valuation index, growth index and solvency index. EBIT increased 82.39% from -$208.4 to -$36.7, and earnings per share increased from -$0.0019 to -$0.0005.
D
Sell
1/2/2020Upgraded
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E on 1/2/2020 due to an increase in the volatility index and total return index.
Primo Nutraceuticals Inc. (BUGVF) was upgraded to D- from E on 1/2/2020 due to an increase in the volatility index and total return index.
E
Sell
10/1/2019Upgraded
Bougainville Ventures Inc. (BUGVF) was upgraded to E from E- on 10/1/2019 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 70.05% from -$240.4 to -$72, EBIT increased 61.94% from -$219.4 to -$83.5, and earnings per share increased from -$0.0035 to -$0.0017.
Bougainville Ventures Inc. (BUGVF) was upgraded to E from E- on 10/1/2019 due to a noticeable increase in the total return index, growth index and volatility index. Operating cash flow increased 70.05% from -$240.4 to -$72, EBIT increased 61.94% from -$219.4 to -$83.5, and earnings per share increased from -$0.0035 to -$0.0017.
E
Sell
7/22/2019Downgrade
Bougainville Ventures Inc. (BUGVF) was downgraded to E- from E on 7/22/2019 due to a substantial decline in the volatility index and total return index.
Bougainville Ventures Inc. (BUGVF) was downgraded to E- from E on 7/22/2019 due to a substantial decline in the volatility index and total return index.
E
Sell
7/17/2019None
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E from U on 07/17/2019.
Primo Nutraceuticals Inc. (BUGVF) was downgraded to E from U on 07/17/2019.
